2018 Investor Presentation

Trulieve Announces January 2022 Investor Conference Participation

January 5, 2022 at 8:00 AM EST

TALLAHASSEE, Fla., Jan. 5, 2022 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced upcoming participation in various investor conferences in January.

  • ICR Conference, January 10, 2022: Founder and CEO Kim Rivers will participate in a fireside chat and investor meetings.
  • ATB Capital Markets 10th Annual Institutional Investor Conference, January 13, 2022: President Steve White will participate in a panel discussion and investor meetings.
  • Needham 24th Annual Growth Conference, January 14, 2022: Founder and CEO Kim Rivers will participate in a panel discussion and investor meetings.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve 
Instagram: @Trulieve 
Twitter: @Trulieve 

Investor Contact
Christine Hersey, Director of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact
Rob Kremer, Executive Director of Corporate Communications
+1 (404) 218-3077
Robert.Kremer@Trulieve.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-january-2022-investor-conference-participation-301454501.html

SOURCE Trulieve Cannabis Corp.